483 Jiangsu YongAn Pharmaceutical Jul 2017

483 Jiangsu YongAn Pharmaceutical Jul 2017

Nadeem Chaudhry FDA$119.00 - Available Now

FDA investigators audited the Jiangsu YongAn Pharmaceutical - Huaian, China facility and issued inspectional observations (via FDA 483) on 07 Jul 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 07 Jul 2017
  • Location: Huaian, China
  • FEI: 3010163907
Add To Cart